Molecular Hydrogen Reverses Sepsis-induced Immunoparalysis: Insights from Longitudinal Deep Immunophenotyping.
Wu CL, Lu JW, Ho YJ, Lui SW, Hsieh TY, Wang KY, Liu FC · In vivo (Athens, Greece) · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The study identified a possible biological mechanism for hydrogen rather than demonstrating a clinical treatment effect.
Hydrogen inhalation sepsis study 2026: what the findings mean
This H2HUBB page translates the technical study record into consumer-friendly language while preserving the scientific details. This uncontrolled human study examined Molecular Hydrogen Reverses Sepsis-induced Immunoparalysis: Insights from Longitudinal Deep Immunophenotyping. The abstract describes Human participants; hydrogen delivered as hydrogen inhalation. Although the patient ultimately succumbed to irreversible chronic comorbidities on day 86, this case of severe tricuspid regurgitation and Child-Pugh class B alcoholic cirrhosis….
Publication: Wu CL, Lu JW, Ho YJ, Lui SW, Hsieh TY, Wang KY, Liu FC, In vivo (Athens, Greece), 2026.
What the researchers studied
Refractory septic shock and post-cardiac arrest syndrome (PCAS) can induce lethal immunoparalysis. However, longitudinal evidence on the effects of molecular hydrogen on deep human…
What effects did molecular hydrogen have?
Observed hydrogen effects: However, longitudinal evidence on the effects of molecular hydrogen on deep human immunophenotyping remains scarce. At a therapeutic impasse marked by high levels of -terminal pro-B-type natriuretic peptide (NT-proBNP) (>35,000 pg/ml) and profound immune depletion, adjuvant hydrogen inhalation was initiated, which led to a 64% reduction in myocardial stress and temporary clinical stabilization.
Why these findings matter
This research helps explain how hydrogen may act at a biological level. It strengthens the scientific rationale for future therapeutic studies, but it does not show that patients will experience a clinical benefit.
How strong is this evidence?
This is direct human evidence with a comparison group.
Technical study details
- Publication type: Uncontrolled human study
- Evidence type: Human clinical evidence
- Research model or population: Human participants
- Hydrogen method: Hydrogen inhalation
Limitations and safety
Important limitations: The abstract alone may not report all methodological limitations; full-text review is required.
Safety information: The abstract did not provide detailed safety or adverse-event information.
Original study and H2HUBB research context
This page explains a published research record and does not turn one study into a medical recommendation. Read the original scientific source for the complete methods, statistics, and author conclusions. Compare this result with related evidence in the H2HUBB Molecular Hydrogen Research Library.